Related Experiment Video
Updated: Jun 15, 2025
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Successful Management of Febrile Infection-Related Epilepsy Syndrome Using Cytokine-Directed Therapy
Dana B Harrar1, Ilyse Genser1, Mejdi Najjar1
1Division of Neurology, Children's National Hospital, Washington, DC, USA.
Insights
This study presents a pediatric case of febrile infection-related epilepsy syndrome successfully treated with early cytokine-directed immunotherapy and avoiding barbiturate coma, leading to good neurologic and functional outcomes.
Area of Science:
- Pediatric Neurology
- Immunology
- Epileptology
Background:
- Febrile infection-related epilepsy syndrome (FIRES) is a severe condition characterized by refractory status epilepticus.
- Traditional treatments can have significant side effects, necessitating alternative therapeutic strategies.
Observation:
- A 5-year-old male presented with fever followed by encephalopathy and super-refractory status epilepticus.
- The patient exhibited a complex cytokine profile during the illness.
Findings:
- Early and aggressive immunomodulatory therapy targeting the patient's cytokine profile was administered.
- A seizure management strategy avoiding barbiturate coma, including ketogenic diet and antiseizure medications, was employed.
- The patient achieved good functional and neurologic outcomes, attending mainstream school with controlled epilepsy and mild neurocognitive impairment.
Implications:
- Cytokine-directed immunotherapy represents a promising therapeutic approach for pediatric FIRES.
- Avoiding barbiturate coma may lead to better long-term neurodevelopmental outcomes in FIRES patients.
- This case highlights the potential of personalized immunomodulatory treatments in severe pediatric epilepsy syndromes.
Abstract:
Here we describe a pediatric patient with febrile infection-related epilepsy syndrome with a good functional and neurologic outcome after treatment with early and aggressive cytokine-directed immunomodulatory therapy and a seizure management strategy that intentionally avoided a barbiturate coma. A 5-year-old previously healthy male presented with staring, behavioral arrest, and encephalopathy evolving to super-refractory status epilepticus. He had had onset of fever 5 days prior. He was treated with early and aggressive immunomodulatory therapy targeted to his evolving cytokine profile. He was also treated with the ketogenic diet, antiseizure medications, and continuous anesthetic infusions. Pentobarbital was purposely avoided. Now, 2½ years later, he attends mainstream school, has attention-deficit hyperactivity disorder (ADHD), mild neurocognitive impairment, and well-controlled epilepsy. By using cytokine-directed immunotherapy and avoiding a barbiturate coma, we were able to successfully treat a pediatric patient with febrile infection-related epilepsy syndrome and achieve a good outcome.
Related Concept Videos
01:14Antiepileptic Drugs: Glutamate Antagonists
01:24Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Electroconvulsive Therapy